{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:04:46Z","timestamp":1778900686675,"version":"3.51.4"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1093\/oxfordjournals.jac.a020890","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T03:40:13Z","timestamp":1334806813000},"page":"25-31","source":"Crossref","is-referenced-by-count":28,"title":["Pharmacodynamics to combat resistance"],"prefix":"10.1093","volume":"46","author":[{"given":"Gary","family":"Woodnutt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,7]]},"reference":[{"key":"key\n\t\t\t\t20170411030633_R1","doi-asserted-by":"crossref","unstructured":"Craig, W. A. (1998). Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases26, 1\u201312.","DOI":"10.1086\/516284"},{"key":"key\n\t\t\t\t20170411030633_R2","unstructured":"Drusano, G. L. & Craig, W. A. (1997). Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. Journal of Chemotherapy9, Suppl. 3, 38\u201344."},{"key":"key\n\t\t\t\t20170411030633_R3","unstructured":"Craig, W. A. & Ebert, S. C. (1990). Killing and regrowth of bacteria in vitro: a review. Scandinavian Journal of Infectious Diseases74, Suppl., 63\u201370."},{"key":"key\n\t\t\t\t20170411030633_R4","doi-asserted-by":"crossref","unstructured":"Craig, W. A. (1995). Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagnostic Microbiology and Infectious Disease22, 89\u201396.","DOI":"10.1016\/0732-8893(95)00053-D"},{"key":"key\n\t\t\t\t20170411030633_R5","doi-asserted-by":"crossref","unstructured":"Craig, W. A. (1996). Antimicrobial resistance issues of the future. Diagnostic Microbiology and Infectious Disease25, 213\u20137.","DOI":"10.1016\/S0732-8893(96)00162-9"},{"key":"key\n\t\t\t\t20170411030633_R6","doi-asserted-by":"crossref","unstructured":"Leggett, J. E., Fantin, B., Ebert, S., Totsuka, K., Vogelman, B., Calame, W. et al. (1989). Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. Journal of Infectious Diseases159, 281\u201392.","DOI":"10.1093\/infdis\/159.2.281"},{"key":"key\n\t\t\t\t20170411030633_R7","doi-asserted-by":"crossref","unstructured":"Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C. & Schentag, J. J. (1993). Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy37, 1073\u201381.","DOI":"10.1128\/AAC.37.5.1073"},{"key":"key\n\t\t\t\t20170411030633_R8","doi-asserted-by":"crossref","unstructured":"Preston, S. L., Drusano, G. L., Berman, A. L., Fowler, C. L., Chow, A. T., Dornseif, B. et al. (1998). Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. Journal of the American Medical Association279, 125\u20139.","DOI":"10.1001\/jama.279.2.125"},{"key":"key\n\t\t\t\t20170411030633_R9","doi-asserted-by":"crossref","unstructured":"Cormican, M. G. & Jones, R. N. (1997). Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone. Antimicrobial Agents and Chemotherapy41, 204\u201311.","DOI":"10.1128\/AAC.41.1.204"},{"key":"key\n\t\t\t\t20170411030633_R10","unstructured":"Moore, T., Kershner, K., Donald, B., Rittenhouse, S. & Coleman, K. (1999). Post-antibiotic effect (PAE) of gemifloxacin (SB-265805) and ciprofloxacin against Gram-positive and Gram-negative organisms. In Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 2298, p. 278. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R11","unstructured":"Credito, K. L., Clark, C. L., Jacobs, M. R. & Appelbaum, P. C. (1999). Post-antibiotic effect (PAE) of gemifloxacin (SB-265805) compared with five other quinolones against pneumococci. In Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 537, p. 21. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R12","unstructured":"Kim, M.-Y., Paek, K.-S. & Choo, Y. S. (1998). SB-265805 (LB20304a): Post-antibiotic effects on Staphylococcus aureus and Escherichia coli. In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract F-088, p. 255. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R13","unstructured":"Paek, K.-S., Kim, M.-Y. & Choo, Y. S. (1998). SB-265805 (LB20304a): Bactericidal activity against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. In Program and Abstracts of the Thirty-Eighth Interscience Conference of Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract F-091, p. 255. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R14","unstructured":"Paek, K.-S., Kim, M.-Y. & Choo, Y. S. (1998). SB-265805 (LB20304a): bactericidal activity against respiratory tract pathogens. In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract F-094, p. 256. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R15","unstructured":"Andes, D. & Craig, W. A. (1999). Pharmacodynamics of gemifloxacin (GEM) against quinolone-resistant strains of S. pneumoniae (SP) with known resistance mechanisms. In Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 2032, p. 50. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R16","unstructured":"Andes, D. & Craig, W. A. (1999). In vivo pharmacodynamic activity of gemifloxacin (GEM) against multiple bacterial pathogens. In Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 27, p. 8. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R17","unstructured":"Andes, D. & Craig, W. A. (1999). In vivo pharmacodynamic activity of sitafloxacin (SIT) against multiple bacterial pathogens. In Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 28, p. 9. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R18","unstructured":"Andes, D. & Craig, W. A. (1999). In vivo pharmacodynamic activity of gatifloxacin (GAT) against multiple bacterial pathogens. In Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 191, p. 10. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R19","doi-asserted-by":"crossref","unstructured":"Thomas, J. K., Forrest, A., Bhavnani, S. M., Hyatt, J. M., Cheng, A., Ballow, C. H. et al. (1998). Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrobial Agents and Chemotherapy42, 521\u20137.","DOI":"10.1128\/AAC.42.3.521"},{"key":"key\n\t\t\t\t20170411030633_R20","unstructured":"Berry, V., Page, R., Satterfield, J., Singley, C., Straub, R. & Woodnutt, G. (1999). Comparative efficacy of gemifloxacin against respiratory tract infection in rats caused by Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy44, Suppl. A, 148."},{"key":"key\n\t\t\t\t20170411030633_R21","unstructured":"Berry, V., Page, R., Satterfield, J., Straub, R. & Woodnutt, G. (1999). Comparative efficacy of gemifloxacin against experimental RTI in rats caused by Haemophilus influenzae. Journal of Antimicrobial Chemotherapy44, Suppl. A, 146."},{"key":"key\n\t\t\t\t20170411030633_R22","unstructured":"Berry, V., Page, R., Satterfield, J., Singley, C., Straub, R. & Woodnutt, G. (1999). Comparative efficacy of gemifloxacin (SB-265805) against experimental respiratory tract infection in rats caused by ciprofloxacin-resistant strains of Streptococcus pneumoniae and Haemophilus influenzae. In Program and Abstracts of the Thirty-Ninth Interscience Conference of Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1999. Abstract 1548, p. 76. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411030633_R23","unstructured":"Berry, V., Page, R., Singley, C., Straub, R. & Woodnutt, G. (1999). Comparative efficacy of gemifloxacin against S. pyogenes and Staphylococcus spp. in skin and soft tissue infections in rats. Journal of Antimicrobial Chemotherapy44, Suppl. A, 148."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/46\/suppl_3\/25\/13056997\/0460025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T14:04:32Z","timestamp":1561644272000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/oxfordjournals.jac.a020890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":23,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2000,7]]},"published-print":{"date-parts":[[2000,7]]}},"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.jac.a020890","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}